This state is predominantly microglial (R2 = 0.23) and encompasses key AD-related pathways, including the TYROBP microglial signaling network, which involves the TREM2 receptor that binds amyloid-beta and activates microglial inflammatory responses (Table S2).76 Here, TYROBP is linked to Alzheimer disease.